Characteristics and overall survival of patients with early‐stage non‐small cell lung cancer: A cohort study in Denmark-Reference-Cited by-同舟云学术

Characteristics and overall survival of patients with early‐stage non‐small cell lung cancer: A cohort study in Denmark

Published:2022-06-20 Issue:1 Volume:12 Page:30-37
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Ehrenstein Vera¹^ORCID,Eriksen Katrine¹,Taylor Aliki²,Servidio Leslie³,Jakobsen Erik⁴

Affiliation:

1. Department of Clinical Epidemiology Aarhus University Aarhus Denmark

2. AstraZeneca Cambridge UK

3. AstraZeneca Gaithersburg Maryland USA

4. Department of Thoracic Surgery Odense University Hospital Odense Denmark

Funder

AstraZeneca

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4946

Reference26 articles.

1. The biology and management of non-small cell lung cancer

2. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

3. The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer

4. NooneAM HowladerN KrapchoM MillerD BrestA YuM et al.SEER Cancer Statistics Review 1975–2015.National Cancer Institute.2017Available from:https://seer.cancer.gov/csr/1975_2015/.

5. Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR mutation testing, treatment and survival in stage I–III non-small cell lung cancer: CancerLinQ Discovery database retrospective analysis;Future Oncology;2024-06-25

2. Molecular alterations and clinical prognostic factors in resectable non-small cell lung cancer;BMC Cancer;2024-02-13

3. EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB–IIIA non-small cell lung cancer in Norway–a nationwide cohort study;Cancer Treatment and Research Communications;2024

4. Inhibition of non-small cell lung cancer (NSCLC) proliferation through targeting G6PD;PeerJ;2023-12-05

5. Diagnostic Workup, Treatment Patterns, and Clinical Outcomes in Early-Stage IB–IIIA Non-Small-Cell Lung Cancer Patients in Denmark;Cancers;2023-10-25